Influenza A viruses target type II pneumocytes and alveolar macrophages in the lungs of mammals [1, 2] . These cells have mechanisms to respond to influenza virus invasion that result in the activation of the innate immune system [3] . Innate immunity is the first line of defense, involving the detection of pathogen-associated molecular patterns (PAMPs). PAMPs are recognized by pattern recognition receptors that include Toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors [4] . RIG-I is an RNA helicase that recognizes viral RNA in the cytoplasm and activates downstream signaling pathways to elicit antiviral type I interferon (IFN) responses via phosphorylation of the transcription factors Interferon regulatory factor (IRF) 3 and Nuclear factor-kappa B (NF-κB) [4] .
Exosomes are membrane-derived small vesicles (30-100 nm in diameter) that originate in the late endosomal membranes that generate intracellular multivesicular bodies (MVBs) [5] . Exosomes are produced in the MVBs and are released into the extracellular environment when the MVBs fuse with the plasma membrane. Since the discovery of functional messenger RNA (mRNA) and microRNA (miRNA) in exosomes [6] , extensive studies have been done to examine the roles of exosomes as mediators of cell-cell communication.
MicroRNAs are small (~22 nucleotides in length), single-stranded noncoding RNAs that mediate the posttranscriptional silencing of target genes. miRNAs bind to the complementary sequence in the 3′-untranslated region (UTR) of their target genes, resulting in targeted mRNA degradation and inhibition of protein expression. Numerous studies have shown altered expression of miRNAs in virus-infected cells, including those infected with influenza virus [7] [8] [9] .
MicroRNAs carried by exosomes function in the host defense against virus infection [10, 11] . Exosomes containing antiviral proteins, mRNAs, and miRNAs that are released from type I IFN-treated liver nonparenchymal cells suppress hepatitis B virus replication in virus-infected hepatocytes [10] . Moreover, miRNA-containing exosomes from placental trophoblasts are delivered to nonplacental recipient cells to elicit antiviral effects against various DNA and RNA viruses [11] . In addition, the profiles of miRNA in bronchoalveolar lavage fluid (BALF) exosomes are altered in patients with asthma, suggesting the involvement of BALF exosomal miRNA in respiratory disorders [12] . However, there have been no reports about the role of exosomes and exosomal miRNA in the innate immune response to influenza virus infection. To understand the roles of exosomes during influenza virus infection, we examined the exosomes that are released into BALF when influenza viruses infect mouse lung. Here we report that miR-483-3p, which we identified in BALF exosomes, plays an important role in the immune response against influenza virus infection in mice.
of the indicated viruses or were administrated 50 µg of poly(I:C) in phosphate-buffered saline (PBS) per mouse. All animal experiments were performed in accordance with the regulations of the University of Tokyo Committee for Animal Care and Use and were approved by the Animal Experiment Committee of the Institute of Medical Science of the University of Tokyo (PA15-10).
Please see Supplementary Data for additional details.
RESULTS

Identification of BALF Exosomes in Influenza Virus-Infected Mice
Given the lack of previous reports describing exosomes in influenza virus-infected mice, we first examined whether BALF exosomes are present in such mice. Mice were infected with 1 × 10 5 PFU of A/Puerto Rico/8/34 (PR8) virus and BALF was collected at 72 hours postinfection (hpi). BALF exosomes were immunogold-labeled with antibodies against CD63, a known exosome marker protein. Labeled exosomes were visualized by using transmission electron microscopy (TEM). In addition to influenza virions (which typically range from 80 to 120 nm in diameter) [13] , we observed small vesicles (approximately 30 nm in diameter), which were CD63-positive on their surface ( Figure 1A , arrows). CD63 was barely detectable on the surface of the virus particles ( Figure 1A , arrowheads). These data indicate that CD63-positive exosomes are released into the alveolar cavity of influenza virus-infected mice. Next, we quantitatively analyzed the levels of BALF exosomes during influenza virus infection by using immunoblotting. We collected BALF from PR8-infected mice at 24, 48, and 72 hpi and isolated exosomes. BALF exosomes collected from naive mice served as a control. The expression levels of the exosome marker proteins CD63 and CD9 increased during influenza virus infection ( Figure 1B ). As CD9, but not CD63, is known to be incorporated into influenza virions [14] , this CD9 increase in BALF may originate from the influenza virions; however, the CD63 increase in BALF suggests that the number of exosomes might also be increased in BALF. The influenza virus nucleoprotein was detected in the same samples, consistent with the TEM findings ( Figure 1A ), indicating that virus particles were present in the BALF in which the exosomes were detected.
Identification of BALF Exosomal miRNA in Influenza Virus-Infected Mice
We hypothesized that influenza virus infection changes the profiles of BALF exosomal miRNAs. We collected BALF from PR8-infected mice at 24, 48, and 72 hpi, isolated BALF exosomes, and performed an miRNA microarray. The levels of the miRNAs that were differentially expressed by >2-fold in influenza virus-infected mice compared with naive mice were increased during infection ( Figure 1C and Supplementary Table 1A) . We hypothesized that miRNAs in BALF exosomes might be involved in the innate immune response to influenza virus infection. To identify them, we intranasally inoculated mice with poly(I:C) and collected BALF exosomes 72 hours later. We performed a miRNA microarray and identified the miRNAs that were differentially expressed in the mice inoculated with poly(I:C) by >2-fold relative to the expression in naive mice and compared them with those from influenza virus-infected mice (Supplementary Table 1B) . We found that some miRNAs were common to both influenza virus infection and poly(I:C) inoculation ( Figure 1D ), suggesting that exosomal miRNAs in BALF may function in the innate immune response to virus infection.
Functional Analysis of BALF Exosomal miRNAs Upon Influenza Virus
Infection
To determine whether BALF exosomal miRNAs influence the innate immune response, we examined the functions of the miRNAs. MLE-12, a mouse cell line of lung epithelial cells, which are targets of influenza virus [1] , were treated with miRNA mimics of 27 miRNAs selected from the results of the microarray analysis (Supplementary Table 1C ). We selected all of the miRNAs that were upregulated at 24 hpi and all of the miRNAs that were upregulated in response to both influenza virus infection (48 and 72 hpi) and poly(I:C) treatment. After treatment with the miRNA mimics, the cells were infected with PR8 (multiplicity of infection [MOI] = 10). We then quantified the gene expression by quantitative reverse-transcription polymerase chain reaction (qRT-PCR).
Of the miRNAs examined, miR-483-3p, miR-374c-5p, miR466i-5p, and miR-203-3p significantly upregulated IFN-β expression ( Figure 2A ). miRNAs that strongly induced IFN-β (ie, miR-483-3p, miR-374c-5p, and miR-466i-5p) also significantly upregulated the gene expression of proinflammatory cytokines and interferon-stimulated genes, including IL-6, CCL2, TNF-α, and SP110 ( Figure 2B ). We then measured IFN-β protein levels in miR-483-3p-, miR-374c-5p-, and miR-466i-5p-treated MLE-12 cells by using an enzyme-linked immunosorbent assay. Treatment with miR-483-3p resulted in the highest IFN-β production ( Figure 2C ). Because influenza A virus NS1 protein inhibits IFN-β induction, we employed a mutant PR8 virus that has 2 amino acid mutations (R38A and K41A) in NS1 that increase the innate immune response to this virus, relative to that of the wild-type, due to a defect in its double-stranded RNA binding activity [15, 16] . Upon NS1-mutant PR8 infection, IFN-β production was significantly higher in miR-483-3p-and miR-374c-5p-treated cells ( Figure 2D ). These results indicate that miRNAs found in BALF exosomes may potentiate the innate immune response. Because miR-483-3p induced the highest level of IFN-β, we focused on miR-483-3p for subsequent analyses.
Identification of BALF Exosomal miR-483-3p in Response to Various
Influenza Virus Strains
To determine whether miR-483-3p is present in BALF exosomes upon infection with influenza virus strains other than PR8, we infected mice with A(H1N1)pdm09, H7N9, or H5N1 influenza viruses.
We collected BALF exosomes at 24, 48, and 72 hpi and performed qRT-PCR. The result showed that a high level of miR-483-3p was detected in BALF exosomes during A(H1N1) pdm09, H7N9, and H5N1 virus infection ( Figure 3A ), suggesting that, regardless of the virus strain, abundant miR-483-3p is present in BALF exosomes upon influenza virus infection.
Expression Levels of miR-483-3p in Lung Tissue and BALF Cells
Since miR-483-3p was present in the BALF exosomes, we also examined its expression in mouse lung tissues. We isolated total RNA from whole lung tissues of mice infected with influenza virus (PR8, pdmH1N1, H7N9, and H5N1). Interestingly, miR-483-3p was not significantly upregulated in lung tissues upon influenza virus infection ( Figure 3B ).
Influenza virus replicates initially in lung epithelial cells. Then, as the virus infection progresses, inflammatory cells such as macrophages and neutrophils accumulate in the alveolar cavity [17] . Therefore, we isolated total RNA from BALF cells to evaluate miR-483-3p expression in the cells that accumulate in the alveolar cavity during PR8 infection. We found that miR-483-3p expression levels were significantly upregulated in BALF cells at 72 hpi ( Figure 3C ). This result indicates that miR-483-3p is upregulated in the cells on the front line of the host innate response to influenza virus infection. . Samples were immunogold-labeled with antibodies against CD63 (arrow: exosomes, arrowhead: virions). Scale bar = 100 nm. B, Immunoblot analysis of BALF exosomes to detect exosomal marker proteins and viral nucleoprotein (NP) during PR8 infection. Equal amounts of BALF were collected at 24, 48, and 72 hpi. BALF exosomes were isolated by means of filtration through a 0.22-µm filter followed by ultra-centrifugation at 100 000g. Exosomes were lysed with sample buffer and used as samples. BALF exosomes isolated from naive mice served as a control. C, BALF exosomes were isolated from mice and exosomal RNAs were analyzed by use of an miRNA array. The number of miRNAs that were expressed at a >2-fold higher level in PR8-infected mice compared with naive mice was compared among the BALF exosomes isolated from the mice at 24, 48, and 72 hpi. D, Venn diagrams represent the number of miRNAs that were commonly or preferentially expressed in the BALF exosomes upon influenza virus infection at each time point and at 72 hours after poly(I:C) inoculation.
To determine which cells upregulate miR-483-3p expression, we collected BALF cells at 72 hpi and stained them with antibodies against CD45, CD11b, and Ly6G. We sorted the cells into 4 populations: CD45 + CD11b + Ly6G high (neutrophils), CD45 + CD11b + Ly6G -/ low (macrophages), CD45 + CD11b -Ly6G -/low (lymphocytes), and CD45 -(nonhematopoietic cells) (Supplementary Figure 1A) [18] .
Cells collected from lung tissues of naive mice served as controls. As shown in Figure 3D , the expression level of miR-483-3p was significantly upregulated in the macrophages and lymphocytes. Given the populations of cells found in BALF, these data suggest that macrophages may be a major source of miR-483-3p-containing exosomes in BALF (Supplementary Figure 1B) . Because miR-483-3p upregulated the expression of IFN-β and proinflammatory cytokines upon influenza virus infection (Figure 2A and 2B), we hypothesized that miR-483-3p may potentiate the innate immune response. IRF3 and NF-κB are transcription factors that regulate the expression of antiviral cytokines [4] . They localize to the cytoplasm in the steady state, but once the RIG-I signaling pathway is activated, they are phosphorylated and translocate to the nucleus. We hypothesized that miR-483-3p might potentiate the activation of IRF3 and NF-κB and upregulate their nuclear translocation. We analyzed the localization of IRF3 and NF-κB in miR-483-3p mimic-treated MLE-12 cells using immunofluorescence. As expected, the nuclear translocation of IRF3 and NF-κB was significantly upregulated in cells treated with the miR-483-3p mimic ( Figure 4A ). These results suggest that miR-483-3p functions upstream of IRF3 and NF-κB in the RIG-I signaling pathway. Next, we investigated whether miR-483-3p affects the RIG-I signaling pathway. MAVS, which is an adaptor protein of RIG-I, transduces the signal downstream and is essential to elicit immune responses [19, 20] . We silenced MAVS using siRNA in MLE-12 cells treated with the miR-483-3p mimic, and quantified IFN-β expression upon poly(I:C) transfection. Upon MAVS silencing, IFN-β induction was strongly attenuated in MLE-12 cells that were not treated with miR-483-3p ( Figure 4B Results are presented relative to those from naive mice (2 −ΔΔCt ). C, Mice were infected with PR8. BALF was collected at 24, 48, and 72 hpi and centrifuged at 1100g for 15 minutes at 4°C to isolate BALF cells. Total RNA was then isolated from the BALF cells. The expression levels of miR-483-3p were quantified by qRT-PCR. Results are presented relative to those from naive mice (2 −ΔΔCt ). D, Total RNA was isolated from sorted cells and qRT-PCR was performed to examine miR-483-3p expression. Cells collected from the lung tissue of naive mice were used as a control. Results are presented relative to those from naive mice (2 −ΔΔCt ). Statistical analysis was performed using 1-way analysis of variance followed by Dunnett test. *P < .05; **P < .01. There were 3 mice per group, except for PR8, which had 6 mice/group (A), and Anhui and VN1203, which had 6 mice/ group (B). Data are presented as the mean ± standard deviation.
Identification of the Target Genes of miR-483-3p
Our results indicated that miR-483-3p potentiates IFN-β by activating the RIG-I signaling pathway. We therefore hypothesized that miR-483-3p targets genes that negatively regulate RIG-I signaling. To identify these target genes, we performed a gene expression microarray using miR-483-3p mimic-transfected MLE-12 cells. We focused on genes that were expressed at a log 0.6-fold lower level than in control miRNA mimictransfected cells. Genes were selected by using miRWalk2.0 [21] , which predicts their likelihood of being targeted by miR-483-3p (Supplementary Table 2) . Of these genes, we focused on RNF5, which was identified as an miR-483-3p target in 8 of the 12 databases examined (miRWalk [21] , miRMap [22] , RNA22 [23] , RNAhybrid [24] , Targetscan [25] , miRNAMap [26] , Microt4 [27] , and miRanda [28] ) and was the fifth highest responder upon miR-483-3p mimic treatment (Supplementary Figure 2) . RNF5 is a negative regulator of the RIG-I signaling pathway [29] ; it targets MAVS and STING for K48-linked ubiquitination and induces protein degradation [29, 30] . We found that RNF5 was downregulated at both the gene and protein levels in miR-483-3p-treated cells ( Figure 5A and 5B). . Data represent the mean of 2 independent experiments. Statistical analysis was performed using Student t test or 1-way analysis of variance followed by Dunnett test. *P < .05; **P < .01. There were 6 technical replicates in each experiment. Data are presented as the mean ± standard deviation.
miR-483-3p Directly Targets the 3′UTR of RNF5
RNF5 has a complementary miR-483-3p sequence in its 3′UTR region. To test whether RNF5 is directly targeted by miR-483-3p, we performed a luciferase reporter assay. We constructed plasmids encoding the wild-type RNF5 3′UTR sequence and a mutated 3′UTR sequence ( Figure 5C ). Luciferase expression was attenuated in the cells transfected with miR-483-3p and the wild-type 3′UTR plasmid but not in cells transfected with the mutated one ( Figure 5D ). This result shows that RNF5 is a direct target of miR-483-3p.
CD81 Is Also a Target of miR-483-3p
miRNAs target multiple genes [31] . We hypothesized that in addition to RNF5, miR-483-3p suppresses other genes involved in the potentiation of innate immunity. Of the genes listed in Supplementary Table 3 , we selected those related to innate immune responses for further analysis; 22 genes were selected as candidate genes involved in enhancing IFN-β expression in response to miR-483-3p. We tested whether these 22 genes were responsible for potentiation of IFN-β by performing siRNA experiments (2 siRNAs per gene). The siRNA-treated MLE-12 cells were infected with PR8 (MOI = 10), and IFN-β expression was quantified by qRT-PCR at 12 hpi. We found that knockdown of CD81 induced significant potentiation of IFN-β expression ( Figure 6A) ) . B, MLE-12 cells were transfected with the miR-483-3p or control miRNA mimic. RNF5 protein expression levels were evaluated by immunoblotting; β-actin served as a loading control. C, The figure shows the predicted target sites of the RNF5 3′ untranslated region (UTR) sequence (top) and miR-483-3p (middle). The mutated target sites are also indicated (bottom). D, Luciferase expression was measured by cotransfecting the miR-483-3p mimic and the wild-type or mutated RNF5 3′UTR luciferase reporter plasmids into MLE-12 cells. Luciferase activity was evaluated at 48 hours posttransfection. The results shown are representative of 2 independent experiments. Statistical analysis was performed by using Student t test. *P < .05; **P < .01. There were 3 technical replicates in each experiment. Data are presented as the mean ± standard deviation.
( Figure 6B ). Among the other 21 genes, we observed an increase in IFN-β gene expression upon knockdown of 4 genes with 1 of the 2 siRNAs tested for each gene (data not shown). For these 4 genes, we tested 2 additional siRNAs and evaluated IFN-β gene expression and gene knockdown levels by using real-time PCR. However, we did not find any correlation between gene knockdown and IFN-β expression. Therefore, we focused on CD81 for subsequent experiments. To address the mechanism of this CD81-mediated regulation of IFN-β, we examined whether CD81 silencing would potentiate the activation of IRF3 and NF-κB in MLE-12 cells. Immunofluorescence revealed that nuclear translocation of IRF3 and NF-κB was significantly upregulated in CD81-knockdown cells ( Figure 6C ). We found that CD81 was downregulated at both the gene and protein levels in miR-483-3p-treated cells ( Figure 7A and 7B) . To analyze whether CD81 is directly targeted by miR-483-3p, we performed a luciferase reporter assay. We constructed plasmids encoding the wild-type CD81 3′UTR sequence and a mutated 3′UTR sequence ( Figure 7C not the mutant, 3′UTR plasmid ( Figure 7D ). This result shows that CD81 is a direct target of miR-483-3p.
DISCUSSION
Recently, miRNAs were reported to be involved in the TLR and RIG-I signaling pathways in various virus-infected cells [32] . The existence of miRNAs that positively regulate the RIG-I signaling pathway suggests that the activation of antiviral responses mediated by miRNAs may be one of the host defense mechanisms [33, 34] . In this study, we sought to identify exosomal miRNAs that are involved in the innate immune response to influenza virus infection. We found high levels of miR-483-3p in exosomes and macrophages in BALF upon influenza virus infection. Given that miR-483-3p was upregulated in BALF macrophages at 72 hpi, exosomal miR-483-3p could be released from monocyte-derived macrophages rather than from lung-resident macrophages. The strategy to focus on BALF exosomes in this study led us to understand the role of exosomal miRNAs in the innate immune response.
Our study is the first to demonstrate the functional involvement of miR-483-3p in the innate immune response to influenza virus infection. Overexpression of miR-483-3p potentiated the expression of IFN-β in a mouse cell line of type II pneumocytes. Knowing that RIG-I is a cytoplasmic pathogen recognition receptor that recognizes influenza virus in epithelial cells, we speculated that miR-483-3p targets Statistical analysis was performed using 1-way analysis of variance followed by Dunnett test. *P < .05; **P < .01. There were 3 technical replicates in each experiment, except for (D), which had 12 technical replicates. Data are presented as the mean ± standard deviation.
negative regulators of the RIG-I signaling pathway. As miRNAs generally target multiple host genes [31] , we screened genes that were responsible for the upregulation of IFN-β and focused on 2 genes, RNF5 and CD81. RNF5 has previously been recognized as a negative regulator of the RIG-I signaling pathway, functioning in the degradation of MAVS and STING via K48-linked ubiquitination in human HEK293 cells [29, 30] . CD81 is a tetraspanin protein, which is a protein that spans the plasma membrane 4 times and forms complexes with other tetraspanins or other functional molecules such as integrins and signaling proteins [35] . The tetraspanins regulate cell morphology, cell invasion, cell fusion, and signaling [35] . Previous studies have suggested that CD9, a member of the tetraspanin superfamily, negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation [36] . Interestingly the expression of IκB is decreased in CD9-deficient macrophages, leading to the activation of NF-κB. Moreover, the double deficiency of CD9 and CD81 in macrophages upregulates the expression of inflammatory cytokines including MMP-2 and MMP-9 [37] , suggesting that CD81 is involved in the regulation of innate immunity. We found that CD81 suppression potentiated the activation of IRF3 and NF-κB. Further experiments are required to identify the mechanism responsible for the enhancement of the innate immune response via suppression of CD81.
In conclusion, our study revealed that lung-derived exosomal miR-483-3p potentiates innate immune responses to influenza virus infection by targeting negative regulators of the RIG-I signaling pathway.
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